Shionogi
Zhengming (Jimmy) Chen has a diverse work experience in the pharmaceutical industry. Zhengming (Jimmy) started their career as a Senior Scientist at Lexicon Pharmaceuticals and Coelacanth in 1997. Zhengming (Jimmy) then joined Purdue Pharma L.P. in 1999 as a Principal Investigator. In 2004, they became the Vice President of Chemistry and Pharmaceutical R&D at DOV Pharmaceutical, Inc. where they oversaw various activities including discovery chemistry, process development, and manufacturing.
In 2009, Zhengming Chen founded ClickChem LLC and served as its President for a year. Zhengming (Jimmy) then held the position of Director of Technical Operations at Aton Pharma, Inc. in 2010, where they led drug product manufacturing tech transfer projects. Later that year, they joined Valeant Pharmaceuticals as a Senior Director and was responsible for managing API development projects.
From 2013 to the present, Zhengming Chen has worked at Shionogi Inc as a Senior Director in Pharmaceutical Sciences, though the specific details of this role are not provided. During their work experience, they also served on the Executive Board of Directors and as Treasurer at LRIG from 2004 to 2013. Overall, Zhengming (Jimmy) Chen has demonstrated expertise in various aspects of pharmaceutical development and management throughout their career.
From 1992 to 1995, Zhengming (Jimmy) Chen pursued a Ph.D. degree in Organic Chemistry at the University of New Orleans.
This person is not in any teams
Shionogi
10 followers
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages their science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.